Ottobock stock trades at EUR 51.15 before its next report

Ottobock stock was trading at EUR 51.15 at Lang & Schwarz on October 8, 2026 at 2:12 p.m. CEST, versus the BMN close of EUR 50.70 on October 7, 2026, a plus 0.89 percent difference. The next quarterly report is scheduled for November 12, 2026.

Revenue and margin improved

Ottobock reported fiscal 2025 core business revenue of EUR 240.0 million, up 11.70 percent. Adjusted EBITDA reached EUR 62.91 million, an increase of 29.50 percent, while the adjusted EBITDA margin rose by 3.60 percentage points to 3.94 percent.

The adjusted group profit was EUR 26.80 million in fiscal 2025, up 83.20 percent. The figures give the stock a fundamental counterweight to its modest intraday price difference and show that earnings growth exceeded revenue growth.

What does the next report add?

According to EQS News on September 22, 2026, Ottobock will publish its third-quarter report on November 12, 2026. The same notice lists a BNP Paribas MidCap CEO Conference on November 16, 2026, giving investors two dated opportunities to assess operating progress and management commentary.

The company operates in prosthetics, neuro-orthotics and exoskeletons. Its investor-relations profile lists more than 100 years of history, business activity in 45 countries and more than 430 patient care centers, which supports a broad distribution platform for future product growth.

Stock stays close to EUR 51

At Lang & Schwarz, Ottobock stock was trading at EUR 51.15 on October 8, 2026 at 2:12 p.m. CEST, versus the BMN close of EUR 50.70 on October 7, 2026, equal to plus 0.89 percent. The neutral price movement leaves the scheduled November report and the recent earnings profile as the clearest measurable reference points. The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.

Market context: Market report DAX.

More news and analyses on Ottobock stock